Articles published by GlobeNewswire

...

Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days

Today 11:24 EST

From Sticker Mule

Via GlobeNewswire

Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs

Today 11:00 EST

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

BLUE OWL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Blue Owl Capital, Inc. and Encourages Investors to Contact the Firm

Today 9:25 EST

From Bragar Eagel & Squire

Via GlobeNewswire

CEPTON URGENT ALERT: Bragar Eagel & Squire, P.C. Reminds Cepton Stockholders of Upcoming December 8th Lead Plaintiff Deadline

Today 9:14 EST

From Bragar Eagel & Squire

Via GlobeNewswire

MAREX URGENT DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Marex Stockholders to Contact the Firm Before December 8th Deadline

Today 9:05 EST

From Bragar Eagel & Squire

Via GlobeNewswire

ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights

Today 8:53 EST

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB

Today 8:34 EST

From The Rosen Law Firm PA

Via GlobeNewswire

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Today 8:30 EST

From Adaptive Biotechnologies

Via GlobeNewswire

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human

Today 8:05 EST

From Io Therapeutics, Inc.

Via GlobeNewswire

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Today 8:05 EST

From Arvinas Inc.

Via GlobeNewswire

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

Today 8:00 EST

From Beam Therapeutics

Via GlobeNewswire

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

Today 8:00 EST

From Aptose Biosciences, Inc.

Via GlobeNewswire

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Today 8:00 EST

From Disc Medicine Inc

Via GlobeNewswire

Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026

Today 8:00 EST

From Bicara Therapeutics Inc.

Via GlobeNewswire

Cardinal Point Wealth Management Releases New 2025 Cross-Border Retirement Guide for High-Net-Worth Families

Today 0:55 EST

From Cardinal Point Wealth Management, ULC

Via GlobeNewswire

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

December 05, 2025

From Junshi Biosciences

Via GlobeNewswire

Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease

December 05, 2025

From Cerevance, Inc.

Via GlobeNewswire

Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

December 05, 2025

From Kirby McInerney LLP

Via GlobeNewswire

ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025

December 05, 2025

From ORIC Pharmaceuticals

Via GlobeNewswire

JHX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – JHX

December 05, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

AB Value Partners, L.P. Announces Proposed Settlement of Stockholder Class Action on Behalf of Former Holders of Orbit/FR, Inc. Common Stock - ORFR

December 05, 2025

From AB Value Partners LP

Via GlobeNewswire

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS

December 05, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group

December 05, 2025

From Webus International Limited

Via GlobeNewswire

Sprouts Farmers Market, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the SFM Class Action

December 05, 2025

From Robbins LLP

Via GlobeNewswire

OWL Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Blue Owl Capital Inc.

December 05, 2025

From Robbins LLP

Via GlobeNewswire

BTDR Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Bitdeer Technologies Group

December 05, 2025

From Robbins LLP

Via GlobeNewswire

AVTR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avantor, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AVTR

December 05, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

December 05, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO

December 05, 2025

From Rocket Doctor AI Inc.

Via GlobeNewswire

CyberloQ Technologies, Inc to Present at the Small Cap Growth Virtual Investor Conference December 9th

December 05, 2025

From Virtual Investor Conferences; CyberloQ Technologies, Inc

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.